Podcasts about GLP

An advert shown during this year's Super Bowl has prompted a backlash on social media. In the ad, tennis champion Serena Williams promotes a weight loss injection, saying she is "healthier" thanks to the product. Many fans have expressed disappointment that a woman associated with strength and body positivity, is now selling being thinner as the ideal. So, is body positivity out and fat shaming back? In our conversations, we discuss the cultural pressure to lose weight now these drugs, known as GLP-1s, are widely available. This episode of The Documentary, comes to you from BBC OS Conversations, bringing together people from around the world to discuss how major news stories are affecting their lives.

When it comes to weight loss, is rebounding actually better than walking, or is it just another fitness trend blowing up your feed? In this episode, Chalene Johnson breaks down the real science behind zone 2 walking vs. rebounding and what actually matters for fat loss, muscle building, and long term results. If you are over 40, trying to lose weight, protect your joints, and avoid wasting money on equipment that ends up holding laundry, you need to hear this. Chalene gets honest about calorie deficits, muscle loss, plateaus, GLP-1 weight loss concerns, and why cardio alone is not the magic answer. Before you buy a rebounder, weighted vest, or the next viral fitness gadget, listen to this. Check out this video on YouTube

GLP-1 drugs are easier than ever to get. But losing weight might also mean losing your personality. This episode was produced by Kelli Wessinger, edited by Jolie Myers, fact checked by Andrea López-Cruzado, engineered by Patrick Boyd and David Tatasciore, and hosted by Jonquilyn Hill. Ads for GLP-1 drugs are everywhere. A Super Bowl commercial for GLP-1 drugs. Photo by Jill Connelly/Bloomberg via Getty Images. Listen to Today, Explained ad-free by becoming a Vox Member: vox.com/members. New Vox members get $20 off their membership right now. Transcript at ⁠vox.com/today-explained-podcast.⁠ Learn more about your ad choices. Visit podcastchoices.com/adchoices

GLP-1s can quiet food noise — but they don't fix stress, self-talk, or lifestyle habits. In this episode, I share: Why fear of regain is so common What actually determines whether weight stays off Wow women use this time on the shot to fix stuff you won't hear a doctor ever tell you about If you're on a GLP-1 and want this to be different, this episode is for you. Get my FREE weightloss videos (The Secrets to How I Lost 100lbs): www.nobsfreecourse.com

In this episode, Dr. Thomas Hemingway goes deep on the Biology of Love and Connection and how you can Renew that Spark in your relationship and also Deepen the connection through Science!He will take you on a fascinating journey from the desire and chemistry of attraction to the deep connection of an enduring committed relationship and the science behind it and how you can augment and deepen your relationship in simple actionable steps.He will also share of an amazing opportunity to go deeper in this area with the Relationship Upgrade program which is a 3-part series available here FREE:Enjoy this powerful podcast and Share with a friend or partner:)Join my Free Masterclass on Midlife Hormones, "Why You Don't Feel like Yourself anymore and What to Do about it!"*ACCESS my FREE workshop, "GET 10 Years Younger, Stronger, and Sharper"  How to turn back your biological age 10-20 years so you can do the things you want to do that you no longer thought possible due to your age.  Perform at your best and live your best life!*And, in my new Performance, and Longevity medical practice we specialize in turning back your biological age and OPTIMIZING HORMONES so you can feel a decade or more younger so you can do the things you want to do that you thought were no longer possible due to your age.  Join the waitlist here!*SHARE with a Friend and please drop a Review:)*Don't wait to Prioritize your health, Start Today with the Simple and Powerful Steps detailed in my Best-selling book.*GET DIRECT ACCESS to DR. HEMINGWAY in these AMAZING COURSES!**Free resource: 'The truth about GLP-1s and their alternatives' - https://drthomashemingway.myflodesk.com/n1yyjkcb68Mahalo and Aloha andTo your health,

February is Eating Disorder Awareness Month. And if you're stuck in quasi-recovery, telling yourself "I'm fine," avoiding help because you're ashamed—this is your wake-up call. I'm sharing 2026 statistics you haven't heard, alarming trends getting WORSE, and the truth about Ozempic, social media, and eating disorders. Because sis, you are not a statistic. At least not a negative one. But you need to hear this. What you'll learn: Why eating disorders increased 15% since 2020 (28.8 million Americans affected) The shocking truth: Every 52 minutes someone dies, only 10% get treatment Midlife crisis: 42% increase in hospitalizations for women 45-65 Ozempic danger: 300% prescription increase, 40% of users have ED histories, 45% relapse when stopping Social media impact: 3+ hours/day = 60% higher ED risk Post-pandemic fallout: 25-30% global increase still climbing My story: When I refused to be a negative statistic 3-question self-assessment to know if you need help NOW The wake-up call: Every day you wait, you're missing out on life. KEY STATISTICS

McDonald’s tests GLP-1 friendly menu. Trump and EPA's Zeldin repeal the endangerment finding, and that's good stuff. The DHS shutdown is coming. Team USA Ice Dancers robbed of Gold. Indy bikeshare program celebrates 1 million rides. The sale of CNN is imminent? Indiana Democrats are big mad over SB 76. Today’s Popcorn Moment: James Van Der Beek reflects on mortality and the meaning of life.Today on the Marketplace: Wedgemaster.RFK Jr exposing California fraud. Tim Walz wants the fraud to continue. See omnystudio.com/listener for privacy information.

McDonald’s tests GLP-1 friendly menu. Trump and EPA's Zeldin repeal the endangerment finding, and that's good stuff. The DHS shutdown is coming. Team USA Ice Dancers robbed of Gold. Indy bikeshare program celebrates 1 million rides. The sale of CNN is imminent?See omnystudio.com/listener for privacy information.

In this Apollo House 2026 fireside chat, StartUp Health community member Sami Inkinen, CEO & Founder of Virta Health, shares how a personal diagnosis of pre-diabetes led him to build one of the fastest-growing companies in metabolic health. Virta Health is proving that Type 2 diabetes and obesity can be reversed with nutrition, supported by technology and AI. Inkinen discusses how Virta has built one of the largest longitudinal biomarker datasets in metabolic disease reversal and is deploying AI agents, supervised by clinicians, to support patients every day. He offers blunt insight into the current standard of care, explains why he believes disease reversal must become the common-sense approach, and shares how Virta became AI-native across every function, from hiring to board strategy. This episode covers: • The future of AI in healthcare operations and patient care • Why food as therapy creates a complex, software-driven challenge • The tension between GLP-1 drugs and root-cause treatment • Scaling a B2B2C healthcare company to sustainability • Advice for founders building in the age of AI As a live recording, the audio reflects the energy of the room rather than a studio setting. Do you want to participate in live conversations with industry luminaries? When you join StartUp Health – a private community for founders, investors, buyers, and industry leaders to connect year-round – you are invited to a full calendar of interactive Fireside Chats with the most influential leaders shaping health innovation. Come with questions, learn what is working right now, and connect with industry icons. » Learn more and join today.

GLP-1 medications like semaglutide, tirzepatide, and emerging GLP-3 drugs are changing weight loss and metabolic health — but what happens when side effects start showing up? In this episode, Liz & Becca break down the real causes behind common GLP-1 side effects including digestive issues, diarrhea, constipation, sleep disruption, blood sugar crashes, body odor changes, microbiome shifts, bile flow dysfunction, and detox overload. You'll learn why GLP-1 medications slow gastric emptying, how they impact bile flow and estrogen clearance, why some people experience microbiome imbalance or SIBO-like symptoms, and how foundational health (liver, gut, electrolytes, protein intake, muscle mass) determines whether GLP-1 works for you or against you. If you're using GLP-1s, considering them, or struggling with side effects — this episode gives you a functional medicine roadmap for safer, smarter use. *** CONNECT:

Get The Lucky Egg Book HereTakeaways:Dr. Lucky Sekhon is a reproductive endocrinologist and author of 'The Lucky Egg'.The pathway to reproductive endocrinology involves extensive training in OB-GYN and specialized fellowship.Social media became a tool for Dr. Sekhon to combat misinformation during the pandemic.Common myths in fertility include the idea that one can reverse the biological clock.Understanding the fertility knowledge gap is crucial for patients seeking help.Insulin resistance plays a significant role in fertility issues, especially in women with PCOS.Fertility treatments should be evidence-based and tailored to individual needs.GLP-1 medications can help regulate menstrual cycles and improve fertility outcomes.Endometriosis can significantly impact fertility and requires tailored treatment approaches.The importance of patient education in navigating fertility treatments cannot be overstated.   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

On Food Talk with Dani Nierenberg, Dani speaks with Ndidi Okonkwo Nwuneli, the President and CEO of the ONE Campaign. They discuss how the dismantling of the U.S. Agency for International Development has impacted the African continent, the opportunities this shifting landscape creates for the emergence of African-led solutions, and the innovative women spearheading food and agriculture systems transformation. Plus, hear about the recent extension of the African Growth and Opportunity Act, severe storm damage in Portugal and Spain causing hundreds of millions of euros in agricultural losses, new recommendations from the World Resources Institute for retailers to help reduce household food waste, and a looming strike at the JBS meatpacking plant in Colorado over alleged inhumane working conditions. Dani also discusses GLP-1 drugs like Ozempic and Wegovy, noting their complex and under-researched impact on people with eating disorders, including both potential benefits and serious risks. While you're listening, subscribe, rate, and review the show; it would mean the world to us to have your feedback. You can listen to "Food Talk with Dani Nierenberg" wherever you consume your podcasts.

Is there a built-in "fat switch" in our genes—something nature designed to help us store fat for survival? And if so, what does that mean for food addicts living in a world saturated with ultra-processed food? In this episode, Dr. Vera Tarman sits down with Dr. Richard Johnson, Professor Emeritus at the University of Colorado, former Chief of the Division of Renal Diseases and Hypertension, author of The Sugar Fix, The Fat Switch, and Nature Wants Us to Be Fat, and a researcher with 700+ scientific papers to his name. Dr. Johnson explains how fructose (from sugar and high-fructose corn syrup—but also produced inside the body under certain conditions) can activate a powerful metabolic pathway that increases hunger, lowers cellular energy, and shifts calories toward fat storage. He connects this to uric acid, salt, high-glycemic carbohydrates, and the modern "perfect storm" of ultra-processed foods engineered to intensify cravings. Together, they explore the evolutionary logic of fat storage, why visceral fat may have had survival value, why "calories in/calories out" fails to explain the whole picture, and what practical steps can help people restore metabolic flexibility—including carbohydrate reduction, movement that supports mitochondrial health, and the emerging role of GLP-1 medications as a tool (not a replacement) for nutrition change. What You'll Learn

Welcome to Indulgence Gospel After Dark! We are Virginia Sole-Smith and Corinne Fay, and it's time for your February Extra Butter episode! Listen to hear about:⭐️ Anti-diet GLP-1 life⭐️ Who gets left out when the tradwife aesthetic takes over influencer culture⭐️ Interrogating the ableism of not wanting to be on medication your whole lifePlus, serious stuff, like:⭐️ Corinne in a prairie dress⭐️ How long Virginia will last in a zombie apocalypse ⭐️ Why hot cheese is in for FebruaryTo hear the whole thing, read the full transcript, and join us in the comments, you do need to be an Extra Butter subscriber.Join Extra Butter!This transcript contains affiliate links. If you're going to buy something we mention, shopping these links supports Burnt Toast at no extra cost to you! Episode 232 TranscriptCorinneToday we are talking about the state of GLP-1 discourse. A few recent media pieces have us wondering if the GLP-1 backlash is finally beginning, and if so, why is all of the coverage still so anti-fat?VirginiaWe're going to use two primary texts for this conversation, but I also want us to talk more generally about how we're seeing the conversation shift, because I feel like there's been an amorphous shift.CorinneI think the initial craze has died down and we're starting to see a more nuanced conversation.VirginiaWhich in many ways is good. There's more nuance on both sides, but there's still a lot of harm being done in the way the media is framing this conversation.CorinneFor sure. VirginiaExhibit A on that front is a piece by Dani Blum that ran on January 15 in the New York Times. The headline is The Hard Truth of Weight-Loss Drugs: You Probably Need Them Forever. Corinne what is your immediate first reaction to that headline?CorinneNo shit, Sherlock. Why were people confused about this?VirginiaI guess people were. It seemed obvious that if a drug makes you lose weight, and you go off the drug, you won't continue to lose the weight.CorinneUnfortunately, except for maybe antibiotics, that seems to be how drugs work. You have to stay on them.VirginiaThere's a lot that comes up for me in this piece. It's looking at new research, bringing to light the fact that when people go off the weight loss drugs, which many people do because they can't tolerate the side effects and it's too expensive, they just get tired of it. There are lots of reasons that people fatigue about being on a weekly injection drug. They're seeing now that people regain the weight. This is being framed as a grave disappointment and a surprise in the article.CorinneNot to me, but to Oprah.VirginiaOprah particularly. Oprah was surprised. They referenced the fact that even Oprah said that she had stopped taking a weight loss drug cold-turkey for a year and then gained back 20 pounds. "I tried to beat the medication," she told People Magazine. It was then she realized it's going to be a lifetime thing. Brilliant marketing for Weight Watchers, Oprah. She thought she could go off it, but you can't. You should be on it forever. So buy your GLP-1s from Weight Watchers. Of course she wants us to be on it forever. She has a business incentive to make that work. It gets into ableism. Why is it problematic to be on a medication for the rest of your life? I have asthma. I expect to use an inhaler to manage that for the rest of my life. I have sleep apnea. I expect to use a CPAP for the rest of my life. Most people with mental health conditions expect to be on an SSRI for the rest of their life. Why is that a problem?CorinneI think there's something about human nature where people think, I don't want to be on a medication for the rest of my life. I've heard so many people say that.VirginiaOften it's the main resistance to starting a medication. Why? What is it about that that makes us sad?CorinneWe want to believe that we're strong and independent and don't need pills to make us ok.VirginiaYou and I are going to wear glasses for the rest of our lives.CorinneI am extremely screwed. So many medications, so many glasses.VirginiaIf the zombie apocalypse comes, I'm out in the first week because if they break my glasses or I lose an inhaler, I'm sorry, I'm not going to try that hard to survive. Even my acid reflux medication - I don't have debilitating acid reflux - but it's irritating. I would be out.CorinneSame. VirginiaTake me now. CorinneI take multiple medications every single day that I would be lost, if not dead, without.VirginiaI don't understand the aversion to that because it's great that I get to breathe through the help of medication. I'm a big fan.CorinneI think what you're hinting at is it's ableism.VirginiaIt's ableism. We want to believe we can overcome these challenges. We see it especially in conditions that are weight linked in any way. This is why people get told to diet before starting a blood pressure or cholesterol medication when those drugs work really well to manage those conditions ... Corinne... and diets don't.VirginiaAnd diets tend to not do so. Is it such a moral failing to have to go on a statin? I don't think so.CorinneThe other thing they're not talking about directly is - and we've talked about this before - that studies show people who take these drugs for conditions like diabetes and/or insulin resistance, don't tend to stay on them long-term because they're hard drugs to be on. VirginiaYeah.CorinneThis article is so sad for people who got to lose weight on these because they will have to be on them forever if they want to "keep the weight off." It's also sad for people who need to take them to manage chronic conditions. These drugs suck in a lot of ways and people don't want to be on them.VirginiaThat's a valid reason to think, I don't want to be on a drug for the rest of my life if it's giving me terrible side effects. My inhalers don't give me terrible side effects. I just like breathing and want to do it all the time. I'm an oxygen addict. If it's a medication that's giving you side effects, I understand not wanting to be on it for life. For folks who are pursuing this just for weight loss, independent of metabolic health, maybe that's a reason to reflect on whether you need to do that. It is a depressing thing to say, "I will be on a medication that gives me diarrhea, fatigue or whatever side effects, but at least I can be a smaller size." That feels like something to reflect on. That reflection is nowhere in this article, however.CorinneThe article doesn't mention side effects at all, does it? VirginiaIt mentions that it's why a lot of people in the studies are going off the drugs. It's this Catch-22 where they're saying, Oh, people are saying, wow, it's so expensive, or, wow, I have terrible side effects, so I go off it. Then they're framing it like those people were quitters. That they gave up. On the other hand, some of this aversion around "you wouldn't want to be on this medication for the rest of your life" is another layer of anti-fatness. The message is we shouldn't let fat people get away with thinness this way. We don't want them passing for thin because they can stay on a GLP-1 forever. We want them to do the "real work" of weight loss.The idea that you could only achieve weight loss by staying on the medication forever makes the weight loss feel fake to people. It's interesting because all intentional weight loss is fake to some extent. It's all manipulating your body in a direction it doesn't naturally want to go in. So why do we penalize medication-based weight loss versus excessive-running-based weight loss?There's also a nice shout-out to RFK, Jr., who also thought the drugs would just be a short-term fix for people and then we'd go back to eating beef tallow to stay thin. Turns out that's not science, but I don't think we're surprised he's not science. Another flavor of anti-fatness in this piece is the casual normalization that you could do this the old fashioned way. In talking about folks who are able to lose the weight even after they go off, the article says:It's not impossible, but it is extremely difficult. Dr Hauser estimates that fewer than 10% of her patients have successfully kept off 75% or more of the weight they lost after going on a GLP-1 without turning to another weight loss medication or undergoing bariatric surgery. "Those are the people that are working out two hours a day, tracking what they eat. They're working really hard," she said. "I haven't had anyone that just tapers off and isn't really putting that much thought into it and just keeps the weight off. I've never seen that happen."That's just casual normalization of eating disorder behavior. Working out two hours a day and tracking what you eat is not a normal way to live.CorinneThe choice is either drugs or an eating disorder.VirginiaThat's not interrogated by this piece, or in any of the discourse I've seen around the whole idea that you have to be on it forever. It's either you have to be on it forever, or we expect you to do this the old fashioned way, like a good fat person would.CorinneIt's also getting into the Rosey Beeme of it all. She lost some weight with a GLP-1 and then was like, Well, I guess weight loss surgery is the way to go here.VirginiaRight, to continue her health journey. I haven't checked on her in a while. Do you know how that's all going?CorinneNo, I don't and I don't honestly want to know. I just think that will become a more common storyline where people are saying, I didn't want to stay on this drug. It didn't lead to permanent weight loss, but maybe bariatric surgery will.VirginiaWell, that's depressing.CorinneSpeaking of influencers, the second article that we wanted to discuss today ran at the beginning of January in Vulture. It's titled ‘Less People Click If You're a Size 16' How plus-size influencers are faring in a GLP-1 world.VirginiaThis one is paywalled. CorinneI'm glad we're talking about this article because I saw so many people whispering about it on social media before I saw it, and then I saw a lot of folks sharing it. The gist of it is that plus-size influencers are not making as much money as before. They're not getting as many brand deals, etc.VirginiaThey're not getting brand deals from fashion brands and other lifestyle brands, which was interesting to me. The plus-size mom influencers, brands don't want them to show the car seat or the stroller anymore.CorinneI think a lot of plus-size influencers would make money from beauty skincare deals. That seems to be where a lot of the marketing money is. Even that area is slowing.VirginiaThe article talks about how one explanation, in addition to the rise of GLP-1s, is the rise of the tradwife aesthetic. An influencer named Joanna Spicer is interviewed quite a bit in the piece. She says:People in the industry, according to Spicer, are “afraid to say anything. It's being danced around. I've been told that I don't fit the criteria to work with the brand because they're more into the tradwife aesthetic. I'm like, ‘Got it.'”With the tradwife aesthetic, a baseline of thin is a given, right? They're all willowy thin blondes like Ballerina Farm. It's interesting that it's not just thin, but the whole Little House On the Prairie conservative fundamentalist perspective. That's what is trending right now. CorinneIt's very depressing. I like Joanna Spicer and that is not her aesthetic. There are plus-size influencers that lean more in that direction who are also suffering.VirginiaBecause they're not leaning enough in that direction.CorinneThey're not living on farms in Utah. I also thought an interesting part of this was her saying that it's being danced around, that no one's straight up saying what's going on.VirginiaOn the flip side, we've also seen (and reported on) a lot of plus-size influencers becoming not plus-size, or attempting to become not plus-size by sharing their GLP-1 journey. While we've had valid criticisms of the way Rosey Beeme and others have articulated those journeys by using a lot of anti-fat rhetoric, I do understand that when you've made your body your business, and now the business is changing, you feel a lot of pressure to change your body to keep up with things.CorinneThis article doesn't mention it, but there have been a couple of brands recently announcing they're not going to make plus sizes anymore, one of which is Christy Dawn, which is a big tradwife aesthetic brand.VirginiaI never did get a Christy Dawn prairie dress while they made them in my size. Now I guess I never will.CorinneI did try one once. It's really not my aesthetic, but it didn't seem nice.VirginiaI kind of wish you had photos. I really can't picture you in a tradwife dress.CorinneI put it on and was horrified.VirginiaYou had a reaction to that like I have to those boiler suit jumpsuits where I feel trapped, have a panic attack and I can't get them off.CorinneThere was too much shoulder. I didn't like it.VirginiaIt's the whole milkmaid thing.CorinneI like my shoulders covered.VirginiaYeah, not your aesthetic. All of this tradwife aesthetic taking over influencer culture and who's getting brand deals also very much ties into how much this is driven by the political climate right now, which is obviously a dumpster fire. Here is another excerpt from the piece:One vice president and an influencer marketing agency who asked to remain anonymous, said that while they haven't seen brands explicitly push back against working with plus-size creators. They are far more hesitant to sponsor any creator who gets even remotely political. What is acceptable now politically may not be in the future, and to avoid any issues, they don't want any voices that are not controlled internally from their side, he said.That made me wonder if fat influencers are more likely to be left wing and progressive than thin influencers. We don't have any data, but my instinct is yes.CorinneThey're probably more likely to be outspoken about size inclusivity, at least.VirginiaPeople think fat liberation is not political or it's not considered part of political action, and it is part of it. They also wrote:"The trend to move away from plus-size clothing aligns with the trend to move away from DEI. It's all related,” says Monica Corbin, a stylist at a plus-size fashion brand. “We had this big explosion during COVID around inclusivity, and I just think there's been the biggest backlash."So what's happening in influencer culture is just a microcosm of our whole country right now?CorinneThere is a part of this article that was so sad. Joanna Spicer was talking about how not being able to get work in your area of expertise makes you feel like a loser. That it's demoralizing and you feel like you've done something wrong. And you don't want to speak out about it because you don't want to screw yourself over in the future. It sounds so isolating.VirginiaThere's often a lot of pressure on influencers not to be transparent about the business model and the money, which is something we see in almost every female dominated industry. Anytime you have an industry that's majority women, people tend to be underpaid and you're encouraged not to talk about money, which is why all of my writer friends know I am extremely transparent about money. Because I feel like this is how any of us make any. It doesn't surprise me that people were so hesitant to go on record for this story because they think they have so much to risk if they say these brands are paying them less. But it also enrages me because these brands are treating you terribly. How else do we put pressure on them to do something different and make different choices?CorinneI don't know, but it's scary to do that now, especially when it feels like there's fear of political retaliation.VirginiaMaybe this is me grasping at a strand of hope, but I do wonder if the fact that Vulture did this story is a positive sign. Will this kind of media coverage put pressure on brands to be more inclusive again? You could read this piece and think, What is Virginia talking about? There's no GLP-1 backlash. The fact that the piece exists feels like a tiny bit of backlash. Or am I just grasping?CorinneWe'll see. It's probably going to take eight years, but I think at least some of the shine is off.VirginiaIt's hard to say that we're definitively in a backlash, or in a moment of change. I don't think we are. I think we are in a moment of increased nuance, and that's where we've landed. There's value in that. There's value in the conversations becoming more nuanced. The last piece we wanted to talk about was Amanda Richard's recent essay about her own experience taking GLP-1s and her take on where we are in this moment. It's called The return of thinness, without the reckoning. What are your thoughts on this piece?CorinneI thought it was really interesting. I read it this morning and haven't fully digested it. The most interesting part to me was this part near the end where she says:What this moment reveals isn't hypocrisy, it's preference, preference for ease over effort, relief over reckoning, for changing bodies instead of changing the rules that they're judged by. Fat acceptance faltered not because it was wrong, but because it asked more of people than a weight loss transformation ever could.She's getting at this moment in culture where people have lower tolerance than ever for friction. We want everything to be as easy as possible, myself included. That's not always what's best for the world, or even ourselves.VirginiaShe's arguing that we're not in a backlash, but that the rise of GLP-1s has legitimized the pursuit of thinness in new ways. She wrote:What's changed isn't the desire to be thin, but the way that desire is explained. It no longer has to pass through shame, discipline or denial, instead arriving framed as care, responsibility and common sense. we've had moral alibis for thinness before diets, program, supplements, lifestyle changes, but they were always imperfect because they still smelled like wanting. They required visible discipline. They demanded effort. They asked people to accept failure when their bodies didn't cooperate. Medicine is a better alibi.I thought that was pretty dead on.CorinneThat's interesting, although we had health as an alibi before.VirginiaWe definitely did. But she's right that making it something that doctors prescribe, that you have to do, and you have to do in very specific ways in order to adhere correctly to it, does feel different from when doctors say, Try to lose some weight and, you know, walk more. It's vague and nebulous and pushes people over to diet culture.Because you're accessing it through consumerism it feels more like something you want, like a choice you're making. There's aesthetic components. I'm doing this celebrity's plan, you know. It feels legitimate now that you're doing it as a responsible choice for yourself because a doctor prescribed it. It's not to say that the medical choices people are making to do these drugs are always wrong, or that it's a bad choice for everybody. Again, it's a great medication for managing diabetes. Because all of the research dollars in the world go towards these drugs, they are discovering other new benefits of them, and that's great if we don't want people to not have those benefits. CorinneWe didn't mention that the whole premise of the piece is that she's taking a GLP-1 for a condition, and it has helped tremendously.VirginiaShe's had some weight loss as a side effect, but that wasn't the primary goal. Fat acceptance needs to keep making more space for those stories and that reality. That is why we added the Anti-Diet Ozempic Life chat room on Burnt Toast, because I was hearing from readers ashamed and confessing to me that they were on a GLP-1 and not having a place to talk about how to do that with integrity and in alignment with their fat liberation values. I was thought, Well, we're doing something wrong if we're making people feel bad about their own individual choices. That's what the other guys do. That's not what we're about. The conversations there have been fascinating and super instructive to me. I've learned a lot. Everybody who's navigating this, if you've identified that fat liberation is one of your values, you have a responsibility to interrogate this thing that Amanda's articulating, how much of this is a moral alibi for thinness, and what does that mean if you're using medicine as your alibi to achieve thinness because of all the other reasons that thinness is valued.CorinneAlthough, in our culture, how can you not? There's always some element of "Being thin is good? Being thinner Is better?"VirginiaBeing prettier? I'll have better access to things. I don't think wanting that for yourself is "wrong" because how could you not want it?CorinneIt's the water we're swimming in. It's hard to make a neutral choice.VirginiaThere is no neutral choice. Articulating that tension to yourself is valuable versus just dressing it up in "I am doing this for x, y and z health reason. I don't care about being thin." Let's be honest. Of course we all care about that a little bit. We're in an interesting place with this stuff. I'm curious to hear what folks think. How you resonated with these articles and what else you're seeing in the discourse. I am glad for the increasing nuance and I wish mainstream media could spot its anti-fat bias even sometimes.

Injectable peptide therapy, a controversial wellness trend that caught fire online in 2025, shows no signs of slowing down in 2026 despite an overwhelming lack of safety data. Peptides, especially “research peptides” like BPC-157 and TB-500, have been hailed by famous podcasters, biohackers, and longevity gurus as a miracle cure for just about anything that ails you, from torn ligaments and gut issues to curbing wrinkles and dull skin. There are several well-studied, FDA-approved peptides available today, such as insulin and GLP-1s like Ozempic and Wegovy, but that's just a sliver of the peptide pie. There are thousands more with glowing online reviews, but scant scientific data, that can be procured online or through longevity clinics. Mixes of various peptides, called “peptide stacks,” often come with clever names like the ‘'wolverine stack' or ‘glow protocol', while others have earned names like ‘Barbie peptide' for their ability to tan the skin without the sun. These popular stacks are not FDA-approved, so they're distributed online as 'research peptides' that are meant for in-lab research, not human use — a workaround for their gray market status. To find out more, host Lexy Lebsack sat down with two experts on the topic. First up was NYT's David Dodge (8:42), who walked us through the rise of peptide therapy online. He published an article for NYT in November titled “The internet loves peptide therapy. Is it really a miracle cure?” Lebsack also interviews McGill's Jonathan Jarry (29:35), who wrote an article in late 2023 — well ahead of a rush of online articles — called “The human lab rats injecting themselves with peptides.” Jarry walks us through the hard science, and lack thereof, of many popular stacks, ahead.

Ibai Llanos ha perdido peso y, a pesar de explicar públicamente que no ha utilizado fármacos tipo GLP-1, parte de las redes sociales ha cuestionado su proceso. La sospecha ha sido automática: “Seguro que ha usado Ozempic”. En este episodio reflexionamos sobre algo mucho más profundo que un caso concreto. ¿Hemos normalizado tanto la medicación para perder peso que ya no creemos en el cambio de hábitos? ¿Estamos medicalizando el cuerpo y patologizando el hambre? ¿Qué dice de nosotros que nos resulte más creíble una inyección que un proceso sostenido en el tiempo?Hablamos de qué son realmente los análogos de GLP-1, cuándo están indicados, qué implicaciones tienen y por qué el debate no debería centrarse en señalar a una persona, sino en analizar la narrativa colectiva que estamos construyendo alrededor del peso, la salud y la cultura de la delgadez.Un episodio para pensar más allá del titular.Conviértete en un supporter de este podcast: https://www.spreaker.com/podcast/comiendo-con-maria-nutricion--2497272/support.

There is something SPECIAL about being in your 50s! Loving life and not giving a SHIT! I truly do not care what people say or do. I'm me and if you love me great if you don't great. Move on my friend. Life just truly gets better with age.If you would like more info on the amazing GLP please reach out by text. 805.440.4909 that way i can get you the correct link. If you're interested in the shot, I can help you with that as well at wholesale. Thank you for being here.

This week, the guys get a little morbid with their discussions. But hey, death is a part of life, and life is funny, so it works! Do the guys think that they'll live to see the year 2100, or will billionaires, AI, and more bring an end to the Earth in the near future? They also discuss their thoughts on modern medicine like GLP-1s, and whether they're good for humanity in the long run. Would either Josh or Evan juice up with some weight-loss drug, or are they wary of the whole thing? Listen in for some fun spins on interesting, dark-ish topics! Plenty of Fact of the Week and "sticking it to the man" tidbits also make appearances, and there are some fun calendar days to review, too!

Send a textSchedule an Rx AssessmentRapid growth is exciting but without the right metrics, culture, and plan, it can quietly put your pharmacy at risk.In this episode, Scotty Sykes, CPA, CFP®, Bonnie Bond, CPA, MBA, and Austin Murray sit down with Jim Hrncir, R. Ph. FACP, Owner of Las Colinas Compounding Pharmacy and Wellness Center veteran compounding pharmacist and owner, to unpack what it really takes to run a sustainable compounding pharmacy through industry cycles, GLP-1 volatility, and ownership transitions.We cover:The KPIs Jim actually tracks to manage a complex compounding operationWhy cash position may be the most overlooked metric in pharmacyHow GLP-1s changed the business—and why diversification still mattersInternal succession vs. private equity: the real tradeoffsAnd more!More About Our Guest:Jim Hrncir RPh and wife Jan founded Las Colinas Pharmacy, Compounding & Wellness in 1984. Recognized as one of the pioneers of modern pharmaceutical compounding, Jim's 1986 creation of Estradiol Transdermal Gel was the first of its kind in the United States. He is responsible for the formulation of many Bio-Identical Hormone, Dermatological, Nutritional, and Anti-Aging compounds in wide use throughout the United States. Jim was named the 2017 Compounding Pharmacist of the Year by Professional Compounding Centers of America (PCCA) and is a Fellow of the Alliance for Pharmacy Compounding (FAPC). NCPA's magazine America's Pharmacist featured Jim and Las Colinas Pharmacy as the cover story for December 2018.Jim has received extensive continuing education in the areas of Bio-Identical Hormones, Nutrition, Anti-Aging Medicine, Weight Management, Pain Management, Neurotransmitter Management, Natural and Functional Medicine including the use of botanical medicines, nutritional supplements, Detoxification and Purification, homeopathy and lab testing. He has lectured across the country on a variety of topics including Clinical Patient Consulting, BHRT Assessment and Case Management, Low Dose Naltrexone, Traumatic Brain Injury Treatment Protocols, and Ketamine for Treatment-Resistant Depression and PTSD.Jim is a member of Professional Compounding Centers of America (PCCA), American Academy of Anti-Aging Medicine, Age Management Medical Group, Texas Pharmaceutical Association, Alliance for Pharmacy Compounding, and the National Association of Community Pharmacists.Stay connected with Jim and Las Colinas Pharmacy: Jim's LinkedInLas Colinas Pharmacy WebsiteLas Colinas Pharmacy FacebookLas Colinas Pharmacy TikTokLas Colinas Pharmacy InstagramLas Colinas Pharmacy LinkedInStay connected with us: FacebookYouTube LinkedInInstagram More resources on this topic: Podcast - Driving Independent Pharmacy Profitability in 2026Podcast – The Startup Compounding Pharmacy Playbook

Hi everyone, I'm Dr. Liza Leal, your host today for the Meridian Medical Dental Healthcare Podcast, powered by Meridian Health Institute — and I'm also known as your Everyday Health Hacker.Today we're talking about what's really happening to your collagen, muscle, and hormones when you're on GLP-1 medications — and more importantly, what you can do to stay looking healthy, strong, and vibrant while you lose weight. A lot of people using GLP medications experience rapid fat loss. While that's wonderful for metabolic health, many people start noticing changes in their skin. Their face can look more hollow or sallow, skin may feel thinner or less elastic, and they may notice sagging in areas like the jawline, neck, arms, or abdomen. So let's talk about how to prevent that.

If you've ever stood at the pharmacy counter shocked by the price of your medication, this episode is for you. From daily thyroid prescriptions to high-demand weight-loss drugs like GLP-1s, drug costs can feel unpredictable—and unfair. In this episode, we break down the new wave of “cheaper prescription” options promising to change the game.We take a closer look at Mark Cuban's Cost Plus Drugs, Amazon Pharmacy and RxPass, and the new Trump Rx pricing initiative—what they offer, how they work, and whether they actually save money on common thyroid medications and weight-loss drugs, as well as other prescription medications. We'll explain which prescriptions are most likely to benefit, where the fine print matters, and why some meds are still frustratingly expensive despite all the headlines.Whether you're managing hypothyroidism, exploring medical weight loss, or paying cash for prescriptions, this episode helps you cut through the noise. 

Jared is joined by original U Up? co-host Sami Sage for a fun episode that kicks off with body image, Ozempic shame, and why vulnerability isn't owed, but it does matter. They unpack a listener's dilemma about dating a woman who may have lost weight on GLP-1s and whether hiding old photos is a red flag, a boundary, or none of his business. Then they review texts from a guy who gives his date the ick by editing his messages multiple times, one edit should be the max! Sami and Jared also discuss what women should actually get men for the upcoming Valentine's Day. Lastly, they dig into two red flag deal breakers: staying close with an ex-wife and being single at 33 – is that a red flag? Learn more about your ad choices. Visit megaphone.fm/adchoices

Stassi and Taylor are finally back in the same room recording without headphones and immediately feel weirdly naked about it. Tay flies in sick but still commits to a very responsible girls' wine night (because priorities), which turns into parent-life chats about kids clocking your wine breath, newborn cuteness rankings (who says 7.8?!), and the universal truth that every child — and adult — goes through at least one painfully awkward phase. Cue Taylor making boys look at her baby pictures and Stassi's full Girls Gone Wild era. They wrap on pure good vibes with the Bad Bunny halftime show so joyful it has them crying, dancing, and remembering there's still hope — and love wins.Thanks for supporting our sponsors:Hiya Health: Receive 50% off your first order. To claim this deal you must go to hiyahealth.com/STASSI.PlutoTV:Pluto TV is your portal to watch free movies and TV shows anywhere, on any device. Download today and discover the easy way to stream all your favorite content. Quince: Go to Quince.com/stassi for free shipping on your order and 365-day returns. Now available in Canada, too.Ro: Go to RO.CO/STASSI to see if you're eligible for the new GLP-1 pill on Ro.Boll and Branch: Get 15% off your first order plus free shipping at BollAndBranch.com/stassi with code stassi.iRestore: Unlock your best skin with @iRestorelaser and unlock exclusive savings on the iRestore Illumina Face Mask, use code Stassi at irestore.com/Stassi! #irestorepodSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Jared welcomes legendary “expert in pessimism” Eddie Pepitone for a Chit Chat Wednesday that somehow turns bleak childhood memories into pure comedy gold. Eddie takes us from soot-covered Brooklyn delis to surviving the Edinburgh Fringe like a stand-up endurance athlete, and he's got some strong feelings about being labeled “the shouty guy.” They get into the weird relationship comics have with their fans, why bad times can weirdly be “Pepitone season,” and what today's stand-up boom is doing to the craft. Then things take an unexpected turn into gym videos, capitalism rants, and a very specific Florida breakfast order that says a lot about a person. Stick around for the menu game and the travel story that proves Eddie might actually chase historic storms on purpose.Jared is on tour!

What if the goal wasn't just to lose weight, but to achieve a balanced "weight health ecosystem"? In this episode, I speak with Ashley Koff about how ultra-processed foods, under-fueling, and disrupted hormones have shaped today's metabolic crisis—and why weight loss alone is the wrong goal. Ashley shares her deeply personal journey and her science-backed framework for understanding weight health, including a clear, honest conversation about GLP-1 medications and how to use them responsibly. Ashley Koff, RD, is the USA Today bestselling author of Your Best Shot (HarperOne) and founder of The Better Nutrition Program (BNP). With over twenty-five years of experience, Ashley's helped redefine how we approach sustainable, lasting weight health. In her new book, Your Best Shot, Ashley introduces weight-health hormones (GLP-1, GIP, CCK, PYY) and offers the first-ever system for assessing and optimizing these hormones, whether you're using GLP-1 medication or not. It's a game-changer for anyone who's felt stuck, blamed themselves, or been failed by traditional dieting. What you'll learn: (02:10) Why ultra-processed foods undermine satiety and metabolic health. (08:05) How dieting and under-fueling can damage digestion, hormones, and muscle. (13:40) What “weight health” means and why weight alone misses the real problem. (15:30) How GLP-1 and other incretin hormones regulate appetite, fat storage, bone, and metabolism. (17:45) Why enriched and ultra-processed foods leave the body under-resourced. (21:00) How GLP-1 medications work differently from the body's natural hormone signals. (24:10) Why fatigue, digestive issues, and muscle loss can happen on GLP-1s when dosing and nutrition aren't optimized. (30:20) Whether it's possible to come off GLP-1 medications and what sustainable success actually looks like. Love the podcast? Here's what to do: Subscribe to the podcast. Leave a review. Text a screenshot to me at 813-565-2627 and wait for a personal reply because your voice is so important to me. Want to listen to the show completely ad-free? Go to http://subscribetojj.com Click “TRY FREE” and start your ad-free journey today! When you're ready, enjoy the VIP experience for just $4.99 per month or $49.99 per year (save 17%!) Full show notes (including all links mentioned): https://jjvirgin.com/yourbestshot Learn more about your ad choices. Visit megaphone.fm/adchoices

*⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SHOPIFY⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠: Sign up for a one-dollar-per-month trial period at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.shopify.com/habitsofagoddess⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ *Brello Health: Go to www.BrelloHealth.com to see if you qualify and explore their GLP-1 plans, starting at $133 per month for your first three months, plus access to their app, community, and wellness classes. *⁠⁠⁠WAYFAIR⁠⁠⁠: Shop all things home at ⁠⁠⁠www.wayfair.com⁠⁠⁠ *⁠⁠⁠⁠⁠⁠⁠⁠⁠DRIPDROP⁠⁠⁠⁠⁠⁠⁠⁠⁠: Stay hydrated this year with DripDrop. Right now, DripDrop is offering podcast listeners 20% off your first order. Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠dripdrop.com⁠⁠⁠⁠⁠⁠⁠⁠⁠ and use promo code ⁠⁠⁠⁠⁠⁠⁠⁠⁠habits⁠⁠⁠⁠⁠⁠⁠⁠⁠. *⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠HERO BREAD⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠: This year, hit your goals without giving up your favorite bready dishes. Hero Bread is offering 10% off your order. Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠hero.co⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and use code ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠HABITS⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ at checkout. *⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠BETTERHELP⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠: Get matched today with a licensed therapist when you visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.betterhelp.com/habitsofagoddess⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠.  *Shop My LTK for all things mentioned in this video: ⁠⁠https://liketk.it/5QWLu⁠⁠ * Follow and connect with me here:  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Tiktok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ https://www.tiktok.com/@jasminerasco1?_t=ZT-90xO4XoWDSH&_r=1⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/habitsofagoddess⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and ⁠⁠⁠ ⁠⁠⁠ ⁠⁠Youtube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.youtube.com/@habitsofagoddess/videos ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ *Here's how to support the podcast: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://buymeacoffee.com/habitofagoddess ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ *Book a Goddess Chat session with me: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://habitofagoddess.com/products/goddess-chat-calls Learn more about your ad choices. Visit megaphone.fm/adchoices

A4M just gave us a front-row seat to what's next in longevity care—here's what we're actually bringing back to Victory (and what we're leaving behind). In this episode, Amy Stuttle is joined by Anna Griffith, DNP at Victory Men's Health to recap the biggest takeaways from A4M in Las Vegas—the largest academic conference in the U.S. for functional and longevity medicine. They break down what stood out, what felt “bright and shiny” but didn't hold up under scrutiny, and what Victory is actually bringing back to patients. You'll hear practical insights on protein quality vs. just “eating more protein,” why amino acids (and leucine thresholds) matter—especially for those fasting or using GLP-1s—and the supplements they're most excited to add, including Perfect Aminos and Urolithin A. Amy and Anna also discuss one of the most talked-about topics at the conference: TB-006 and Galectin-3 as an emerging area of research for neurodegenerative disease symptom support, plus the complementary role of modified citrus pectin. They wrap with an update on the exploding peptide conversation—what's real, what's marketing, and why clinical oversight matters—and a look at new longevity tools Victory is adding at the new location, including VO2 max testing as part of a more complete longevity strategy. If you've been wondering what's next in longevity medicine—and what's worth your time versus hype—this episode gives you the real-world, clinician-level breakdown. My favorite air purifier for 15% off. Code VICTORY $200 off a Sunlighten Sauna click HERE WorldLink Medical BHRT training. For 10% off use CODE Victory2026. Victory Men's Health Click Here Victory Men's Health YouTube For questions email podcast@amystuttle.com Disclaimer: The Women Want Strong Men Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional healthcare services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Thank you for tuning in for another episode of Life's Best Medicine. Dr. William Davis is a cardiologist and best-selling author of multiple books aimed at exposing the incredible nutritional blunders made by official health agencies and providing effective and powerful strategies for regaining health, gaining control over weight, and even methods to regain youthfulness. His books include Wheat Belly, Undoctored, Super Gut, and his latest release, SUPER Body. In this episode, Dr. Brian and Krisna talk about… (00:00) Intro (05:38) Why doctors and the medical industry in general are so slow to accept new scientific discoveries and, especially, to admit that they've been wrong (13:45) Problems with GLP-1s (21:51) Dr. William Davis' new book, SUPER Body (link below) (39:53) Lectin intolerance and how to fix it (42:40) Why making homemade yogurt from very particular strains of microbes can be so beneficial (46:30) Hyaluronic acid (48:42) Safely transitioning off of GLP-1s (56:47) Outro and plugs For more information, please see the links below. Thank you for listening!   Links: Dr. William Davis: Dr. Davis Infinite Health Inner Circle: https://innercircle.drdavisinfinitehealth.com/landing/default.aspx X: https://x.com/WilliamDavisMD IG: https://www.instagram.com/drdavisinfinitehealth/?hl=en Additional Links: https://linkin.bio/drdavisinfinitehealth/ SUPER Body (book): https://www.amazon.com/gp/product/0306835991?tag=hacboogrosit-20   Dr. Brian Lenzkes:  Arizona Metabolic Health: https://arizonametabolichealth.com/ Low Carb MD Podcast: https://www.lowcarbmd.com/   HLTH Code: HLTH Code Promo Code: METHEALTH • • HLTH Code Website: https://gethlth.com

In this deeply personal episode, I sit down with Mary-Caitlin and Dan, a couple who navigated the challenges of PCOS and fertility treatment to welcome their son Jack. Alongside their incredible doctor, Dr. Joshua Hurwitz from Illume Fertility, we explore what it really means to face a PCOS diagnosis and how the right medical support combined with unwavering partnership can transform a difficult journey into a story of success.  Mary-Caitlin shares her experience from being diagnosed at age 20 to enduring multiple losses before finding hope through IVF, while Dan offers a loving partner's perspective on being present through every step of the process. Throughout our conversation, we dive into the medical realities of PCOS: from understanding it as an ovulation issue rather than an infertility diagnosis, to optimizing IVF protocols specifically for PCOS patients. Dr. Hurwitz breaks down the science behind modified natural transfer cycles, the importance of metabolic health, and exciting developments in PCOS treatment including GLP-1 medications.  Read the full show notes on my website. In this episode, we cover: How PCOS affects ovulation and fertility, and why it's not a diagnosis of infertility The emotional impact of receiving a PCOS diagnosis as a young woman and how to communicate with partners Optimizing IVF protocols for PCOS patients, including medication dosing, trigger types, and birth control lead-ins Modified natural transfer cycles and why they may reduce pregnancy complications like preeclampsia The importance of metabolic optimization, nutrition support, and treating the whole person, not just the fertility issue How GLP-1 agonist medications can change PCOS management for long-term health Practical advice for couples: letting go of timelines, maintaining life outside of treatment, and supporting each other through the process Resources: Illume Fertility (Dr. Joshua Hurwitz's practice): https://illumefertility.com Illume on Instagram: https://www.instagram.com/illumefertility/ Guest: Dr. Joshua Hurwitz, Reproductive Endocrinologist at Illume Fertility Patients: Mary-Caitlin & Dan Other ways to reach me: Visit my YouTube channel for more fertility tips! Subscribe to the newsletter to get updates. Join Egg Whisperer School. Request a Consultation with me. Dr. Aimee Eyvazzadeh is one of America's most well-known fertility doctors. Her success rate at baby-making gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org.     #PCOS #Fertility #IVF #TTC #ReproductiveHealth #FertilityJourney #Pregnancy #WomensHealth

Would you believe that there's a medication that can quiet the constant mental chatter around food for the first time in your adult life, but it could also cause you to lose muscle, age your face, and trap you in a cycle that's hard to escape? Both of those are true. When a drug can help someone lose 50 pounds and get off diabetes medication, that's a miracle. But when that same drug leaves someone unable to eat, losing muscle, and facing a lifetime of injections just to maintain their weight—that's a conversation we truly need to have. So, today we're taking a deep dive into GLP-1s—Ozempic, Wegovy, Mounjaro, and what's coming next. How to preserve muscle when taking GLP-1 medications Consume 1.2–1.6 g of protein per kilogram of body weight daily, spread across meals  Try to eat something containing 25–30 grams of protein within about two hours after doing a strength workout Consume easily digestible protein sources when your appetite is low (shakes, yogurt, collagen, or bone broth) Commit to doing resistance training at least two to three times a week Monitor your body composition for any early signs of muscle loss  Bio: Stephanie Gray Stephanie Gray, DNP, MS, ARNP, AGNP-C, ABAAHP, FAARFM, is a functional medicine provider helping men and women build sustainable, optimal health and longevity. A nurse practitioner since 2009, Dr. Gray completed her doctorate focusing on estrogen metabolism from the University of Iowa in 2011 and holds a Master's in Metabolic Nutritional Medicine from the University of South Florida's Medical School. Dr. Gray is one of the Midwest's most credentialed female healthcare providers. She completed an Advanced Fellowship in Anti-Aging, Regenerative, and Functional Medicine in 2013 and became Iowa's first BioTe certified provider—now the state's only platinum provider with over 10,000 pellet placements. She is also certified as a SIBO doctor-approved practitioner, mold-literate provider, and ReCODE 2.0 practitioner for cognitive decline prevention. An Amazon best-selling author, Dr. Gray wrote Your Longevity Blueprint and Your Fertility Blueprint, and hosts the Your Longevity Blueprint podcast. She co-founded Your Longevity Blueprint Nutraceuticals with her husband, Eric. After her own ten-year fertility journey, she now specializes in helping couples optimize reproductive health through functional medicine. Having lost her grandmother to vascular dementia, she is personally committed to helping families avoid cognitive decline. Dr. Gray founded the Integrative Health and Hormone Clinic in Hiawatha, Iowa. In this episode: How muscle preservation becomes non-negotiable when your appetite is suppressed Why protein timing matters more than total calories when on GLP-1 medications The importance of resistance training when taking GLP-1s The value of in-body scans for catching any muscle loss that may be occurring early on Why tapering off GLP-1 medications starts on day one, not at the finish line How natural GLP-1 stimulation can support or extend the effects of GLP-1 medications Why body composition, not weight loss, determines long-term outcomes when taking GLP-1s How the next generation of GLP-1 agonist drugs could improve our longevity Links and Resources: Relative Links for This Show: Use CODE BERBERINE to get 10% off ⁠⁠⁠Berberine  ⁠⁠⁠⁠⁠⁠Use Code FIBER to get 10% off GLP-1 Fiber Follow Your Longevity Blueprint  On Instagram| Facebook| Twitter| YouTube | LinkedIn Get your copy of the Your Longevity Blueprint book and claim your bonuses here Find Dr. Stephanie Gray and Your Longevity Blueprint online   Follow Dr. Stephanie Gray  On Facebook| Instagram| Youtube | Twitter | LinkedIn Integrative Health and Hormone Clinic Podcast production by Team Podcast

In this week's episode of Medicine: The Truth, hosts Jeremy Corr and Dr. Robert Pearl examine a sweeping set of developments shaping American healthcare. From the first state-approved use of generative AI to prescribe medications without human oversight to rising healthcare costs, from worsening vaccine misinformation to the stubborn persistence of preventable disease, this show focuses on biggest stories in medicine today. The episode opens with a groundbreaking and controversial pilot program in Utah that allows a generative AI system to renew prescriptions for chronic disease without physician involvement. From there, the conversation turns to the relentless rise in healthcare spending. New federal data show Americans now spend more than $15,700 per person annually on medical care, with costs growing twice as fast as the economy. While insurance coverage remains high for now, Pearl warns that expiring subsidies, Medicaid restrictions and rising premiums are already pushing millions out of coverage. For many families, healthcare affordability has become a top issue and, increasingly, a political fault line heading into the midterm election cycle. Here are more major storylines from MTT episode 103: Exercise as medicine for depression: A large meta-analysis finds that regular exercise can be as effective as antidepressant medication for many patients. Trump's healthcare plan fades quickly: Pearl explains why the president's proposal disappeared from the headlines. Measles returns in force: Cases are nearing 1,000 and outbreaks concentrated in under-vaccinated communities. Vaccine battles intensify under RFK Jr.: New appointments to federal advisory committees raise alarm among scientists, as anti-vaccine voices gain influence. Chronic disease remains America's top killer: Cardiovascular disease continues to claim nearly one million lives annually. Generative AI's biggest promise: Pearl makes the case that AI-driven, at-home monitoring could finally transform chronic disease management. Cancer trends turn ominous: Colorectal cancer deaths among Americans under 50 are rising sharply, becoming the leading cancer killer in this age group. Genetics vs. lifestyle revisited: New research suggests genetics may account for half of lifespan variation but lifestyle still determines how many of those years are lived in good health. High-deductible health plans: New data show cancer patients with high-deductible insurance have significantly higher mortality. GLP-1 weight-loss pills arrive: The first oral GLP-1 drug launches to record demand. A devastating flu season for children: Despite the availability of safe vaccines, pediatric flu deaths reach alarming levels among unvaccinated kids. As the episode closes, Dr. Pearl delivers a stark warning about the resurgence of pseudoscience in medicine. Tune in for more fact-based coverage and analysis of healthcare's biggest stories.   * * * Dr. Robert Pearl is the author of the new book “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine” about the impact of AI on the future of medicine. Fixing Healthcare is a co-production of Dr. Robert Pearl and Jeremy Corr. Subscribe to the show via Apple, Spotify, Stitcher or wherever you find podcasts. Join the conversation or suggest a guest by following the show on Twitter and LinkedIn The post MTT #103: Can generative AI safely prescribe medicine on its own? appeared first on Fixing Healthcare.

Cameron discusses the critical role of practice owners in managing their medical practices effectively. He emphasizes the importance of accountability, understanding financial metrics, and making data-driven decisions rather than relying on feelings. He also highlights the need for effective marketing strategies and the transition from being a practice owner to a CEO and investor in the practice. The conversation aims to empower practice owners to take control of their business and achieve financial success.Listen In!Thank you for listening to this episode of Medical Millionaire!Takeaways:The biggest problem in practice management is often the practice owner themselves.Accountability is crucial for financial freedom and practice success.Relying on feelings rather than data can lead to poor business decisions.Understanding financial metrics is essential for evaluating practice performance.Marketing strategies should be data-driven to effectively grow the practice.Transitioning from practice owner to CEO requires a focus on numbers and strategy.Investing in business education and consulting can enhance practice management skills.Effective communication with patients about services can drive sales.Practices should analyze their service distribution to identify growth opportunities.Becoming an investor in your practice is key to long-term success.Medical Millionaire: The Blueprint for Scaling a World-Class Medical Aesthetics PracticeWelcome to Medical Millionaire, the go-to podcast for forward-thinking Medspa owners, Medical Aesthetics leaders, Plastic Surgery & Dermatology practices, Concierge Wellness clinics, and Elective Healthcare entrepreneurs who are ready to scale with intention and operate like a true, high-performing business.If you're building, growing, optimizing, or preparing to exit your aesthetics or wellness practice, this show is your competitive advantage.Hosted by Cameron Hemphill Your Guide to Sustainable, Scalable Growth Your host, Cameron Hemphill, is one of the most trusted growth strategists in Medical Aesthetics and Elective Wellness.With over 10 years in the industry, Cameron has helped scale 1,000+ practices and more than 2,300 providers, working alongside the most recognized KOLs, national brands, EMRs, tech companies, and private equity groups, shaping the future of aesthetics. From marketing to operations, from finance to leadership, Cameron brings a real-world, data-driven perspective on what it takes to turn a practice into a powerful business engine.What This Podcast Is All About: Each episode takes you behind the scenes of the fastest-growing practices in the country, revealing the systems, strategies, and mindset required to win in today's Medical Aesthetics landscape.Expect tactical insights, step-by-step frameworks, and conversations with:Industry thought leadersTop injectors & medical directorsEMR & tech innovatorsOperations expertsMarketing strategistsPrivate equity & M&A advisorsWellness and longevity pioneersThis is where aesthetics, business, technology, and wellness converge. What You'll Learn on Medical Millionaire Every week, you'll access expert guidance to help you scale profitably and predictably, including:Marketing & Brand PositioningCRM + Lead Management SystemsPatient Acquisition & ConversionEMR Optimization & Tech Stack ArchitectureSales Psychology & Consultation MasteryFinance, KPIs, and Practice EconomicsOperational Workflows & AutomationIndustry Trends Backed by Real Benchmark DataPatient Retention & Lifetime Value ExpansionMindset, Leadership & Team DevelopmentWhether you're opening your first location or running a multi-million-dollar enterprise, you'll gain the clarity and direction to grow with confidence. A Show Designed for Every Stage of Practice Growth Medical Millionaire breaks down the journey into four essential stages, showing you exactly how to move from one to the next:Startup – Build the foundation and attract your first wave of patientsGrowth – Scale revenue, expand services, and strengthen operationsOptimize – Increase efficiency, margins, and customer experienceExit – Prepare your practice for maximum valuation and acquisitionIf You're Ready to Grow, This Is Where You Start. Tune in weekly for actionable insights, expert interviews, and the exact playbooks high-performing practices use to dominate their markets. This is the podcast for Medspa owners who want more than a job; they want a scalable, profitable, industry-leading business. Welcome to Medical Millionaire.Let's build your practice into the empire it deserves to be.

DianeKazer.com/PEPTIDES Apply to Become a Patient --> DianeKazer.com/PATIENT Join Our VIP Tribe --> DianeKazer.com/VIP What if weight loss resistance, low energy and metabolic burnout were never a willpower problem? In this episode, we break down what almost no one is talking about: • Why GLP production in the gut has quietly collapsed • Why weight loss resistance is not a personal failure • Nor is the myth of any 'obesity gene' like Oprah Winfrey claims

In this special series on Oral GLP-1 Receptor Agonists, Dr. Neil Skolnik will discuss the first of the GLP-1 RAs to receive FDA approval, Semaglutide.  This special episode is sponsored with support from Novo Nordisk. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health W. Timothy Garvey, MD.,  Butterworth Professor and University Professor of Medicine in the Department of Nutrition Sciences at the University of Alabama at Birmingham. Selected references: Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. Knop, Filip K et al. The Lancet, Volume 402, Issue 10403, 705 – 719 Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. Wharton Sean et al. N Engl J Med 2025;393:1077-1087 Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. Lincoff, A Michael, et al.  N Engl J Med 2023;389:2221-2232  

Not many digital health companies go public. And even fewer do so with a model designed to fix what's truly broken in U.S. healthcare: episodic, fragmented care that fails to support the behavior change required to manage chronic disease. Omada Health CEO Sean Duffy joins Claudia to discuss the company's journey from scrappy startup to public company—and his biggest ambition for the future: bending the nation's chronic disease curve, both in cost and in human suffering. Claudia and Sean talk about:Omada's “full stack” approach to chronic careWhat Omada's IPO signals for digital health's futureWhy GLP1s are a catalyst for behavior changeHow employers have quietly driven healthcare innovationSean says for Omada to actually shift what consumers pay out of pocket every month for their premiums we need to make big changes:“Affordability is the thing… That's the burden we're bearing as a country… And so, the only way to bring down healthcare costs are completely transformed care models. That's the only way… Thank goodness we're at a moment where those models are being supported and being scaled nationally. Thank goodness we're at a moment where technologies like AI can help add even more efficiency and help scale… Our only way out are different care models [that] leverage new technologies.”Relevant LinksAccess more info in Omada's research libraryGet details on Omada Health's S1 IPO Filing See the GLP-1 research Sean mentions: Omada members maintain weight loss after discontinuing GLPsGet more info on the CMS ACCESS model About Our GuestSean Duffy co-founded Omada in 2011 with the aim of merging medical trends and cutting edge technology to revolutionize health care of chronic disease as we know it. Today, he proudly serves as CEO and has been instrumental in steering Omada toward global recognition, such as being hailed a potential “medical triumph” by The New York Times, and one of Fast Company's 50 most innovative companies in the world. A longtime devotee of healthcare and technology, Sean also founded a largely automated lifestyle business around Excel Everest, the interactive Microsoft Excel training tool he created. He formerly covered healthcare innovation as writer and editor for Medgadget, a popular medical technology blog. As CEO of Omada, Sean cares deeply about honing the organization's exceptional products, values-driven approach to healthcare, and the innovative ways in which primary care can continue to better humanity. More recently, Sean has been spending more and more of his free time learning how to build and fly first-person view drones.SourceConnect With...

Dr. David Unwin shares his journey from traditional medical practices to becoming a leading advocate for low-carb diets in managing diabetes. He discusses the significant improvements he has observed in his patients' health through dietary changes, the challenges posed by vested interests in healthcare, and the importance of continuous glucose monitoring. The discussion also touches on the misconceptions surrounding diabetes treatment, the role of GLP-1 medications, and the influence of historical figures like Dr. Wolfgang Lutz and Weston A. Price on modern nutritional understanding.Chapters00:00 Introduction to Dr. David Unwin01:45 The Shift from Medication to Nutrition07:01 Understanding the Resistance to Dietary Change11:20 Common Misconceptions in Diabetes Treatment14:43 Patient-Centric Approaches in Diabetes Management18:21 The Role of Continuous Glucose Monitors20:45 The Importance of Feedback in Behavior Change24:23 Exploring Blood Testing and Its Implications29:41 The Debate on Dietary Fat and Diabetes38:11 The Phenomenon of GLP-1 Medications38:35 The Complexities of GLP-1 Usage43:46 Food Addiction and Societal Pressures47:03 The Impact of Low-Carb Diets01:02:01 Lessons from Weston A. Price

Send a textIs being inactive more dangerous than we think? In this clip from our episode “Why Exercise Beats Longevity Hacks”, CareTalk host John Driscoll speaks with Dr. Jordan Metzl, Author of The Athlete's Book of Home Remedies, about why movement may be the most powerful preventive medicine we have, even in the era of GLP-1s.Listen to the full episode here

GLP-1 medications like Ozempic and Wegovy are everywhere—and so are the opinions. In this episode, Andrew breaks down what GLP-1 actually is (a natural gut hormone), how GLP-1 medications work, and why newer “dual agonist” options like Mounjaro/Zepbound tend to produce bigger weight-loss results. We also tackle the controversy: is obesity a disease, and are GLP-1s “taking the easy way out”?You'll hear a coach's perspective from years in the trenches—why weight loss is effortless for some people and brutally hard for others, what typical results look like, common side effects, why many people stop, and what usually happens when you discontinue the meds.Chapters00:00 — Why GLP-1s are “big” right now01:12 — How common is obesity and GLP-1 use?05:20 — Obesity as a disease09:10 — The blame game12:40 — Are GLP-1's the easy way out?23:16 — GLP 101: what it is and what it does31:30 — Results, side-effects, and plateausThe Co-Movement Gym Podcast is supported by Native Path Supplements and Lombardi Chiropractic.

Craig Carton and Chris McMonigle take a wild ride from weight-loss trends to sports immortality. A caller proudly talks about being on GLP-1… which sparks a hilarious debate does Ozempic make people BORING?! Then the conversation turns nostalgic and emotional… remembering Mickey Mantle, meeting Joe DiMaggio, and the rare athletes whose deaths were so massive their funerals were televised nationwide. From Mantle to Muhammad Ali… to Kobe Bryant… who today would truly stop the country?

Why are most Americans struggling with weight gain, obesity, and the serious health problems that follow? Dr. Hotze explains how being overweight has become one of the most widespread health issues in the United States, contributing to diabetes, heart disease, fatty liver disease, high blood pressure, and more. He explores why these numbers have risen so dramatically over the past several decades and why this trend is largely unique to America. Dr. Hotze discusses two major drivers behind weight gain: a slowed metabolism due to impaired thyroid function and the overconsumption of processed, high-carbohydrate foods. He explains how fluoride exposure can interfere with thyroid hormone activation, reducing metabolism and energy production, while excess sugar and simple carbohydrates drive insulin resistance and fat storage. The conversation also addresses the growing use of GLP-1 medications, such as Semaglutide, outlining how they work, why they produce rapid weight loss, and the potential risks associated with muscle loss, digestive complications, and long-term health consequences. This episode emphasizes that lasting weight loss is not achieved through quick fixes or expensive medications, but through sustainable lifestyle changes. Dr. Hotze shares real-life success stories and explains how adopting a clean, whole-food eating plan, restoring metabolic balance, and committing to long-term habits can lead to profound improvements in health, energy, and vitality. The message is clear: taking charge of your health naturally can transform not only your weight, but your overall quality of life. For more information about the Body Reboot Program, visit BodyRebootChallenge.com. Watch now and subscribe to our podcasts at www.HotzePodcast.com. To receive a FREE copy of Dr. Hotze's best-selling book, “Hormones, Health, and Happiness,” call 281-698-8698 and mention this podcast. Includes free shipping!

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.In this milestone episode of The Healthy Diabetic Podcast, I'm joined by longtime friend and former co-host Graham Hubbard for Episode 330—and the first-ever live episode of the show.Graham and I dive into a wide-ranging, honest conversation about whether modern diabetes technology has truly made life easier for people with Type 1 diabetes—or if something important has been lost along the way.They explore topics including insulin sensitivity, fear of lows, CGMs, fitness, food quality, GLP-1 medications, obesity trends in Type 1 diabetes, and the emotional weight of living with a misunderstood condition. The episode also introduces the new live format, with weekly discussions happening in real time and continuing on YouTube.This episode sets the tone for what's coming next: deeper conversations, more nuance, and a stronger focus on the real-life factors that impact diabetes beyond numbers and devices.

This Day in Legal History: Nelson Mandela ReleasedOn February 11, 1990, Nelson Mandela was released from Victor Verster Prison in South Africa after 27 years of incarceration, marking a seismic shift in the country's legal and political landscape. Mandela's release followed a period of secret negotiations between the apartheid government and the African National Congress (ANC), and it signaled the beginning of the end of apartheid—a system of institutionalized racial segregation and oppression upheld by law. His imprisonment had become a global symbol of the fight against racial injustice and was frequently challenged by international human rights organizations and legal scholars as a violation of fundamental human rights.Mandela had been convicted in 1964 of sabotage and other charges under South Africa's Suppression of Communism Act, following the infamous Rivonia Trial. He was sentenced to life imprisonment, spending much of his sentence on Robben Island under harsh conditions. Over the decades, growing international sanctions and internal unrest made apartheid increasingly untenable.Then-President F.W. de Klerk's government began rolling back apartheid legislation in the late 1980s, and on February 2, 1990, de Klerk announced the unbanning of the ANC and his intention to release Mandela. Just nine days later, Mandela walked free, delivering a speech in Cape Town that emphasized reconciliation, peace, and the continuation of the struggle for full democratic rights.Mandela's release was not just a political milestone—it was a legal one, too. It reflected a move away from laws based on racial supremacy and toward a constitutional order grounded in human rights. This transformation would culminate in South Africa's 1996 Constitution, often lauded for its rights-based framework and independent judiciary.The Trump administration's plan to repeal the EPA's 2009 endangerment finding—the scientific basis for regulating greenhouse gases under the Clean Air Act—could reignite legal efforts to hold polluters accountable through public nuisance lawsuits. That finding enabled the EPA to regulate emissions from vehicles and power plants, but its reversal removes the legal framework that had previously shielded companies from such claims under a 2011 Supreme Court ruling. In that decision, the Court held that the EPA's authority under the Clean Air Act displaced common-law nuisance suits against emitters. Without that EPA oversight, legal scholars believe plaintiffs may now argue that the courts are once again an appropriate venue for these claims.Public nuisance lawsuits, typically filed by states or municipalities, seek to hold companies accountable for harms caused to community health and safety. These cases have been historically difficult to win due to challenges in proving direct causation, but experts say the new regulatory gap could encourage a wave of litigation. Industry groups like the Edison Electric Institute have warned that repealing the endangerment finding could expose utilities to costly legal battles. While federal courts had largely blocked such claims, state courts have shown more openness, and the shift in federal policy may strengthen these legal efforts. Environmental advocates may now have renewed leverage to push power companies and other emitters into court.Trump's repeal of climate rule opens a ‘new front' for litigation | ReutersAttorney General Pam Bondi is scheduled to testify before the House Judiciary Committee this week amid intensifying legal scrutiny over the Justice Department's management of the Jeffrey Epstein files. Lawmakers are expected to question Bondi about what they view as excessive redactions and the DOJ's withholding of key documents, actions that may conflict with a bipartisan federal law passed in 2025 mandating the broad release of Epstein-related materials. Legal analysts suggest the DOJ's reliance on legal privileges—such as investigatory and deliberative process exemptions—to justify redactions could face stiff challenges in court or through congressional oversight powers.The situation raises constitutional tensions between legislative oversight and executive privilege, particularly as the House panel, now under Republican control, examines whether the DOJ is shielding politically sensitive information. Some members of Congress have accused the Department of undermining transparency and potentially violating the statutory intent of the Epstein Disclosure Act, which narrowed the DOJ's discretion in withholding records tied to convicted sex offenders or deceased suspects like Epstein.Bondi's DOJ has been accused of prioritizing partisan enforcement over institutional neutrality, illustrated by failed prosecutions of Trump critics and an aggressive posture on immigration and protest-related cases. The sidelining of the DOJ's civil rights division and the refusal to investigate federal shootings has further fueled concerns over selective enforcement and erosion of prosecutorial independence. Bondi's testimony will serve as a key moment to defend the Department's use of legal redactions and its broader approach to politically charged prosecutions.Bondi to face questions on Epstein files in House testimony | ReutersInstagram chief Adam Mosseri is set to testify in a Los Angeles courtroom this week in a groundbreaking lawsuit that could reshape how U.S. law approaches the intersection of product design and youth mental health. The case centers on a 20-year-old plaintiff who alleges she became addicted to Instagram as a child due to its deliberately addictive interface—particularly the “endless scroll” feature that loads content continuously to hold user attention. Her lawyers argue that Instagram's design choices amount to a form of negligent product engineering that failed to account for known risks to children.This case raises novel legal questions: Can user interface (UI) design be treated as a defective product under tort law? Can tech companies be held liable not just for content but for the architecture of the platforms themselves? If the court accepts these arguments, it could establish precedent for treating addictive design as a public health harm similar to tobacco or opioid marketing practices.Mosseri is expected to face questioning over internal documents that, according to the plaintiff, show Meta was aware of the app's mental health impact on vulnerable teens. Meta counters that these documents reflect efforts to mitigate harm, not evidence of negligence. Still, the case may test the limits of Section 230 immunity, as it focuses not on third-party content, but the platform's own design—potentially sidestepping the traditional legal shield for tech companies.Hundreds of similar cases are pending, and this trial may serve as a bellwether for litigation nationwide. International developments, including Australia's ban on social media for children under 16, suggest this is a growing legal frontier.Instagram's leader to testify in court on app design, youth mental health | ReutersNovo Nordisk's recent patent infringement lawsuit against Hims & Hers marks a pivotal legal development in the pharmaceutical industry's battle with telehealth providers distributing compounded drugs. The suit, filed in Delaware federal court, targets Hims' sales of compounded semaglutide—the active ingredient in Wegovy and Ozempic—claiming these formulations infringe Novo's patents. While compounding is allowed under certain FDA exemptions, those exemptions do not shield pharmacies or telehealth platforms from patent liability. This case challenges the assumption that FDA compliance protects against infringement claims, exposing a gray area where regulatory and intellectual property regimes collide.Historically, brand-name drugmakers focused on trademark challenges over how compounded drugs were marketed. Novo's move into patent litigation signals a strategic escalation: it's not about branding anymore—it's about the act of making and selling the compound itself. Experts highlight that this is likely the first time a brand drug company has pursued patent claims directly against a compounding pharmacy or telehealth distributor, suggesting the industry now sees these entities as substantial commercial threats.The case also underscores a novel enforcement strategy: suing the telehealth platform facilitating sales rather than the dispersed network of compounding pharmacies, streamlining legal action and potentially setting precedent for centralized liability. Hims, already under regulatory scrutiny, had just halted plans to sell compounded semaglutide pills but remains a target due to its involvement in injectable forms.The outcome of this case may clarify how FDA-sanctioned compounding intersects with patent protections and could define the boundaries for how far telehealth companies can go in offering customized versions of patented drugs.Novo's GLP-1 Patent Suit Against Hims Takes Aim at Compounding This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.minimumcomp.com/subscribe

Hasan, Austin, and Jen go down the blueanon rabbit hole.

This week your girlies are back with their usual chaos!We are pondering how do you talk to kids about why some people pee standing up and others don't, testing their global knowledge on world flags, Becky unveils an exciting new business chapter and we talk about how to talk to your friends about their kids' behavior.This is episode is half cozy, half chaos and we wouldn't want it any other way!To submit an Is It Karma Or Is It Chaos story email us at info@karmachaospodcast.comShop merch hereFor full videos head to patreon.com/kaillowry Follow Becky at Hayter25 and subscribe to For The HaytersThank you for supporting the show by checking out our sponsors! OPositiv: take proactive care of your vaginal health head to opositiv.com/karmaQuince: Go to quince.com/karma for free shipping on your order and 365-day returns. Tonal: Right now, Tonal is offering our listeners $200 off your Tonal purchase go to tonal.com and use promo code KARMA.RO: Go to ro.com/karma for your free insurance check. That's ro.com/karma to see if your insurance covers GLP-1s for free.BetterHelp: Visit betterhelp.com/KARMA to get 10% off your first month.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

GLP 1 medications are everywhere, and most conversations swing between hype and shame. This episode slows it all down.   We cover what GLP 1 actually is (a natural satiety and blood sugar hormone), how GLP 1 medications work in the gut and brain, what the research shows so far, and what it still does not answer. We talk about why these meds can feel life changing for food noise and cravings, plus the tradeoffs that often get minimized, like nausea, constipation, fatigue, under eating, and muscle loss.   This is not a pro or anti episode. It is a physiology first conversation to help you ask better questions and make thoughtful decisions, whether you are curious, considering it, or already using one.   Hosted by Leanne Vogel.   Coaching with Leanne: https://www.healthfulpursuit.com/coaching    Bioactive Peptides: https://www.healthfulpursuit.com/make     Quiz - your personalized peptide stack: https://www.healthfulpursuit.com/quiz    Enjoy today's show. Thanks for listening!  

SPONSORS: - Check out the new show from Ian Fidance "IAN DO: AN ODD GUY DOIN ODD JOBS" new episodes every other Tuesday! https://youtube.com/@ianfidancecomedy?si=qUc9UfdpJ6im9xmj - Go to https://ro.co/FIRSTDATE to see if you're eligible for the new GLP-1 pill on Ro. Lauren Compton sits down with comedian Dan St. Germain for a hilarious deep dive into awkward first dates, wild drinking stories, and unforgettable life experiences. From meeting his wife and lifelong friendships, to corsets, “Power Boobs,” pumping like a cow, epic video game moments, and even aliens, UFOs, and Bigfoot theories—this episode is packed with laughs, cringe, and shocking stories you won't want to miss.

What does the Bible say about health and fitness? In the third episode of our Not Just Sacred series, we take a Christian look at the body, the soul, and how they're meant to work together. We explore whether fitness matters to God, how Scripture warns against being ruled by food or consumption, and why aging is something the Bible honors rather than resists. From questions about appearance and motivation to modern conversations around tracking, diets, Botox, and GLP-1s, this episode offers biblical principles for navigating health wisely without turning it into an idol. We also announce the winning book for our Not Just Sacred book club!

The peptide industry just hit $328 million in imports from China in nine months, and the fastest-growing buyers aren't bodybuilders. They're women in their 30s, 40s, and 50s who were told their labs look "fine" when they know something is deeply wrong.In this episode, I break down why peptides like BPC-157 and TB-500 are being aggressively marketed to women in perimenopause, why there isn't a single randomized controlled trial proving they're safe or effective in humans, and what the actual evidence says about brain fog, muscle loss, joint pain, and metabolic decline. I explore why the "your bloods are normal" dismissal has destroyed women's health, how hormone replacement therapy actually protects your brain when timed correctly, why GLP-1s work when peptides don't, and what protein, sleep, and resistance training do that no research chemical can replicate, because the foundations of brain health will never trend on TikTok, but they're the only things backed by decades of rigorous science. *Reduce your risk of Alzheimer's with my science-backed protocol for women 30+: * https://go.neuroathletics.com.au/youtube-sales-page Subscribe to The Neuro Experience for evidence-based conversations at the intersection of brain science, longevity, and performance. *TOPICS DISCUSSED* 00:00 Intro: Why women are the fastest-growing peptide buyers 07:01 Perimenopause reality: why "your labs look fine" is destroying women's health 15:20 What peptides actually are and the missing human evidence 31:00 Quality control disasters and documented side effects 39:50 What actually works: resistance training, protein, and muscle preservation 44:30 Hormone replacement therapy and brain protection 51:14 GLP-1 receptor agonists: evidence-based use vs. gray market risks *Thank you to our sponsors* Caraway: https://carawayhome.com/neuro10 Timeline Mitopure: http://timeline.com/NEURO Function Health: https://www.functionhealth.com/tcm/louisanicola _______ I'm Louisa Nicola - clinical neurophysiologist - Alzheimer's prevention specialist - founder of Neuro Athletics. My mission is to translate cutting-edge neuroscience into actionable strategies for cognitive longevity, peak performance, and brain disease prevention. If you're committed to optimizing your brain- reducing Alzheimer's risk - and staying mentally sharp for life, you're in the right place. Stay sharp. Stay informed. Join thousands who subscribe to the Neuro Athletics Newsletter → https://bit.ly/3ewI5P0 Instagram: https://www.instagram.com/louisanicola_/ Twitter : https://twitter.com/louisanicola_ Learn more about your ad choices. Visit megaphone.fm/adchoices

Send a textMatt and Steve dive deep into Dr. Silkworth's groundbreaking work on alcoholism and why understanding the medical nature of addiction changes everything. They explore a fascinating discovery: Silkworth published his "allergy theory" in a 1937 medical journal—two years before the Big Book—challenging the common AA legend about why he initially hesitated to put his name in print.The hosts discuss why the Doctor's Opinion matters less for its 1939 medical accuracy and more for what it tells newly sober people: you have a condition, not a character flaw. Matt and Steve get real about the difference between the physical reality of addiction (not your fault) and the actions taken while drinking (your responsibility to address).Steve shares his own parallel journey with weight management and GLP-1 drugs, drawing powerful connections between different types of medical conditions that were once viewed as moral failings. The conversation unpacks why self-knowledge alone isn't enough to stay sober, the role of dopamine in addiction, and why removing shame is the first barrier that needs to fall.Whether you're brand new to sobriety or years into recovery, this episode offers a compassionate, science-informed perspective on what's really happening in your brain and body—and why that understanding is the foundation for everything that follows.Links to the two articles Silkworth wrote in 1937:Alcoholism as a Manifestation of AllergyReclamation of the AlcoholicSupport the show

#938: Join us as we sit down with Dr. Gabrielle Lyon – board-certified, fellowship-trained physician, New York Times bestselling author & founder of Muscle-Centric Medicine®. After years of clinical practice, Dr. Gabrielle Lyon identified a revolutionary pattern: her patients weren't suffering from excess fat – they were undermuscled. This critical insight changed everything. In this episode, Dr. Gabrielle gets real about the role of protein, the truth about organ meats in nutrition, the benefits & risks of semaglutide, how to strategically use GLP-1's, the importance of building a strong skeletal muscle system at every age, & insights from her latest book, The Forever Strong Playbook.    To Watch the Show click HERE   For Detailed Show Notes visit TSCPODCAST.COM   To connect with Dr. Gabrielle Lyon click HERE   To connect with Lauryn Bosstick click HERE   To connect with Michael Bosstick click HERE   Read More on The Skinny Confidential HERE   Head to our ShopMy page HERE and LTK page HERE to find all of the products mentioned in each episode.   Get your burning questions featured on the show! Leave the Him & Her Show a voicemail at +1 (512) 537-7194.   To learn more about Dr. Gabrielle Lyon visit https://drgabriellelyon.com.   This episode is sponsored by The Skinny Confidential The beauty tool that started it all, redesigned to evolve with you. Shop Ice Roller at https://bit.ly/IceRollerSilver.   This episode is sponsored by HERS Check out http://Forhers.com to learn more.   This episode is sponsored by Cozy Earth  Head to http://cozyearth.com and use my code SKINNY for up to 20% off.    This episode is sponsored by BetterHelp Sign up and get 10% off at http://BetterHelp.com/skinny.   This episode is sponsored by The RealReal Get $25 off your first purchase when you go to http://TheRealReal.com/skinny.    This episode is sponsored by Just Thrive Get your health in check and save 20% on your first order at https://justthrivehealth.com/SKINNY with code SKINNY.   This episode is sponsored by Hiya Health Go to http://hiyahealth.com/SKINNY and get your kids the full-body nourishment they need to grow into healthy adults.   This episode is sponsored by IQBAR Text SKINNY to 64000 to get 20% off all IQBAR products, plus FREE shipping. Message and data rates may apply.   Produced by Dear Media